cft

Healthcare Distribution Market Size To Gain US$ 1,380 Billion By 2030

The global healthcare distribution market sizeprojected to grow from USD 981.63 billion in 2022 to reach around USD 4.1 billion by 2030, progressing a CAGR of 19.57% from 2022 to 2030. The global healthcare distribution market size projected to grow from USD 981.63 billion in 2022 to reach around USD 4.1 billion by 2030, progressing a CAGR of 19.57% from 2022 to 2030.


user

roshan salunke

a year ago | 6 min read

The global healthcare distribution market sizeprojected to grow from USD 981.63 billion in 2022 to reach around USD 4.1 billion by 2030, progressing a CAGR of 19.57% from 2022 to 2030.

Distribution in a vital part of the healthcare industry supply chain. It embodies all wholesalers and distributors of health care products. This can comprise of companies anywhere from wholesalers of equipment to the pharmacies. The rise in production of medical equipment and drugs has resulted in the growth of distribution industry. With a strong distribution business, equipment and drug companies can effectively supply their commodities to multiple hospitals and other health care organizations.

Healthcare distributors procure pharmaceutical products from producers and distribute them to an assortment of customers, comprising of long-term care facilities, hospitals, and retail and other pharmacies among others. Some of the wholesalers sell to an extensive range of potential customers while others focus on sales of specific products (e.g., biologics) or sales to certain types of clients (e.g., pediatric clinics).

Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1259

Growth Factors

Factors such as rising incidence of chronic diseases and rapid progress of medical devices industry are driving the growth of healthcare distribution market. The frequency of chronic diseases has risen quickly in past few years due to increasing geriatric population globally. As per the WHO data, the prevalence of chronic disease will surge to 57% by 2021. This growth is expected to be the most substantial in the developing nations. A suitable healthcare distribution structure is therefore essential around the world, and has become a requirement. A synchronized and robust healthcare response is essential in every part of the world. Chronic diseases are some of the most rampant and expensive health conditions in the United States. Approximately half of all American people suffer from a minimum of one chronic ailment, and the count is growing. Internationally, almost one in three of all grownups suffer from multiple chronic conditions (MCCs) which are among the largest reason of the demise in the world.

The medical device business is poised for firm growth, with worldwide annual sales prediction to rise by over 5% a year and reach nearly US$800 billion by 2030. These estimates reflect growing demand for innovative new devices (like wearables) and services (like health data). This is majorly due to increasing prevalence of lifestyle diseases and high economic growth in emerging markets – particularly China and India.

Report Highlights

  • Among the product type segment, pharmaceuticals are expected to dominate the overall market. Formation of new industrial facilitates by global pharmaceutical companies in new geographies, growing expenditure on pharmaceutical research and development activities, rising production of pharmaceutical preparations, and outsourcing of pharmaceutical manufacturing to the Asian nations is supporting the sector growth. Biopharmaceuticals are expected to advance at a significant CAGR in the estimate timeframe majorly due to increasing applications.
  • The retail pharmacies accounted for the largest revenue in the end user segment with more than 52.5% share in 2020. Implementation of programs to guarantee accessible health care for people in the US and other developed countries which subsequently increase the quantity of prescription is the major factor responsible for high market share of retail pharmacies.
  • McKesson Corporation accounted for the highest share of over 16% of the global healthcare distribution market.

Regional Analysis

The report covers data for North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. In 2020, North America dominated the global market with a market share of more than 38.5%. U.S. accounted for the highest share in North America majorly due to the presence of major companies and early launch of latest products. Pharmaceutical distributors form the core of the healthcare ecosystem in North America. These distributors take care of around 92% of medical sales and add capability and order to a supply chain which links two enormously fragmented markets.

Europe was the second prominent market majorly due to favorable reimbursement scenario and presence of latest healthcare infrastructure. The presence of skilled researchers in the European region is also expected to boost the demand for healthcare distribution market in the near future. Asia Pacific is expected to grow at the highest CAGR of around 9% in the forecast period due to high investment by major market players. Latin America and the Middle East and African region will exhibit perceptible growth.

Key Market Players and Strategies

The major companies operating in the worldwide healthcare distribution are AmerisourceBergen Corporation, McKesson Corporation, Medline Industries, Cardinal Health, Inc., PHOENIX Group, Shanghai Pharmaceutical Group Co., Ltd., Henry Schein Inc., Owens & Minor, Inc., Medline Industries, and Rochester Drug Cooperative, Inc. among others.

Distributors play a crucial role in sustaining the integrity of the current closed-loop supply chain by merging manufacturer orders, distributing products to pharmacies, and dispensing returns. Some of the significant tactics undertaken by leading market participants to withstand the aggressive market competitiveness comprise of acquisitions, mergers, and collaborations.

Market Segmentation:

By Product Type

  • Biopharmaceutical
  • Pharmaceutical
  • Medical Device

By End User

  • Hospital Pharmacies
  • Retail Pharmacies
  • Other End Users

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Table of contant

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Healthcare Distribution Market, By Product

7.1. Healthcare Distribution Market, by Product Type, 2021-2030

7.1.1. Biopharmaceutical

7.1.1.1. Market Revenue and Forecast (2017-2030)

7.1.2. Pharmaceutical

7.1.2.1. Market Revenue and Forecast (2017-2030)

7.1.3. Medical Device

7.1.3.1. Market Revenue and Forecast (2017-2030)

7.1.4. Others

7.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Healthcare Distribution Market, By Application

8.1. Healthcare Distribution Market, by Application, 2021-2030

8.1.1. Hospital Pharmacies

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Retail Pharmacies

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Others

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Healthcare Distribution Market, Regional Estimates and Trend Forecast

9.1. North America

9.1.1. Market Revenue and Forecast, by Product (2017-2030)

9.1.2. Market Revenue and Forecast, by Application (2017-2030)

9.1.3. U.S.

9.1.3.1. Market Revenue and Forecast, by Product (2017-2030)

9.1.3.2. Market Revenue and Forecast, by Application (2017-2030)

9.1.4. Rest of North America

9.1.4.1. Market Revenue and Forecast, by Product (2017-2030)

9.1.4.2. Market Revenue and Forecast, by Application (2017-2030)

9.2. Europe

9.2.1. Market Revenue and Forecast, by Product (2017-2030)

9.2.2. Market Revenue and Forecast, by Application (2017-2030)

9.2.3. UK

9.2.3.1. Market Revenue and Forecast, by Product (2017-2030)

9.2.3.2. Market Revenue and Forecast, by Application (2017-2030)

9.2.4. Germany

9.2.4.1. Market Revenue and Forecast, by Product (2017-2030)

9.2.4.2. Market Revenue and Forecast, by Application (2017-2030)

9.2.5. France

9.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

9.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

9.2.6. Rest of Europe

9.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

9.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

9.3. APAC

9.3.1. Market Revenue and Forecast, by Product (2017-2030)

9.3.2. Market Revenue and Forecast, by Application (2017-2030)

9.3.3. India

9.3.3.1. Market Revenue and Forecast, by Product (2017-2030)

9.3.3.2. Market Revenue and Forecast, by Application (2017-2030)

9.3.4. China

9.3.4.1. Market Revenue and Forecast, by Product (2017-2030)

9.3.4.2. Market Revenue and Forecast, by Application (2017-2030)

9.3.5. Japan

9.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

9.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

9.3.6. Rest of APAC

9.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

9.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

9.4. MEA

9.4.1. Market Revenue and Forecast, by Product (2017-2030)

9.4.2. Market Revenue and Forecast, by Application (2017-2030)

9.4.3. GCC

9.4.3.1. Market Revenue and Forecast, by Product (2017-2030)

9.4.3.2. Market Revenue and Forecast, by Application (2017-2030)

9.4.4. North Africa

9.4.4.1. Market Revenue and Forecast, by Product (2017-2030)

9.4.4.2. Market Revenue and Forecast, by Application (2017-2030)

9.4.5. South Africa

9.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

9.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

9.4.6. Rest of MEA

9.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

9.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

9.5. Latin America

9.5.1. Market Revenue and Forecast, by Product (2017-2030)

9.5.2. Market Revenue and Forecast, by Application (2017-2030)

9.5.3. Brazil

9.5.3.1. Market Revenue and Forecast, by Product (2017-2030)

9.5.3.2. Market Revenue and Forecast, by Application (2017-2030)

9.5.4. Rest of LATAM

9.5.4.1. Market Revenue and Forecast, by Product (2017-2030)

9.5.4.2. Market Revenue and Forecast, by Application (2017-2030)

Chapter 10. Company Profiles

10.1. AmerisourceBergen Corporation

10.1.1. Company Overview

10.1.2. Product Offerings

10.1.3. Financial Performance

10.1.4. Recent Initiatives

10.2. McKesson Corporation

10.2.1. Company Overview

10.2.2. Product Offerings

10.2.3. Financial Performance

10.2.4. Recent Initiatives

10.3. Medline Industries

10.3.1. Company Overview

10.3.2. Product Offerings

10.3.3. Financial Performance

10.3.4. Recent Initiatives

10.4. Cardinal Health, Inc.

10.4.1. Company Overview

10.4.2. Product Offerings

10.4.3. Financial Performance

10.4.4. Recent Initiatives

10.5. PHOENIX Group

10.5.1. Company Overview

10.5.2. Product Offerings

10.5.3. Financial Performance

10.5.4. Recent Initiatives

10.6. Shanghai Pharmaceutical Group Co., Ltd.

10.6.1. Company Overview

10.6.2. Product Offerings

10.6.3. Financial Performance

10.6.4. Recent Initiatives

10.7. Henry Schein Inc.

10.7.1. Company Overview

10.7.2. Product Offerings

10.7.3. Financial Performance

10.7.4. Recent Initiatives

10.8. Owens & Minor, Inc.

10.8.1. Company Overview

10.8.2. Product Offerings

10.8.3. Financial Performance

10.8.4. Recent Initiatives

10.9. Medline Industries

10.9.1. Company Overview

10.9.2. Product Offerings

10.9.3. Financial Performance

10.9.4. Recent Initiatives

10.10. Rochester Drug Cooperative, Inc.

10.10.1. Company Overview

10.10.2. Product Offerings

10.10.3. Financial Performance

10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research

11.2. Secondary Research

11.3. Assumptions

Chapter 12. Appendix

12.1. About Us

12.2. Glossary of Terms



You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333













Upvote


user
Created by

roshan salunke


people
Post

Upvote

Downvote

Comment

Bookmark

Share


Related Articles